Status:
COMPLETED
Virtual Immersive Communication Training on Recommending Immunizations
Lead Sponsor:
Brittany Rosen
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Human Papilloma Virus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our approach will be to implement Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), an intervention that includes a self-directed app based curriculum and VR simulation...
Detailed Description
Background: Despite strong evidence the human papillomavirus (HPV) vaccine is effective in preventing certain anogenital cancers, only 65% of adolescent females and 56% of males in the U.S. have init...
Eligibility Criteria
Inclusion
- Physician (Attending or Resident) at control or intervention clinic
- Staff Member (Medical Assistant or Nurse) at intervention clinic
Exclusion
- N/A
Key Trial Info
Start Date :
June 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT04368455
Start Date
June 23 2020
End Date
December 1 2022
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229